Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs191320-   
Low Rs107231-   
Sales per share (Unadj.) Rs75.195.1-  
Earnings per share (Unadj.) Rs-5.5-24.0-  
Cash flow per share (Unadj.) Rs0.9-19.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.774.6-  
Shares outstanding (eoy) m61.25168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.9 68.7%   
Avg P/E ratio x-27.1-11.5 235.9%  
P/CF ratio (eoy) x170.0-13.9 -1,226.8%  
Price / Book Value ratio x1.13.7 29.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,14246,446 19.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,2652,915 43.4%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m4,59916,052 28.7%  
Other income Rs m517112 459.6%   
Total revenues Rs m5,11616,165 31.6%   
Gross profit Rs m47-2,782 -1.7%  
Depreciation Rs m391693 56.5%   
Interest Rs m44435 10.2%   
Profit before tax Rs m128-3,797 -3.4%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466237 196.2%   
Profit after tax Rs m-337-4,045 8.3%  
Gross profit margin %1.0-17.3 -5.9%  
Effective tax rate %363.5-6.2 -5,817.8%   
Net profit margin %-7.3-25.2 29.1%  
BALANCE SHEET DATA
Current assets Rs m5,62311,757 47.8%   
Current liabilities Rs m3,2976,615 49.8%   
Net working cap to sales %50.632.0 157.9%  
Current ratio x1.71.8 96.0%  
Inventory Days Days59111 52.9%  
Debtors Days Days48124 38.5%  
Net fixed assets Rs m7,0286,853 102.6%   
Share capital Rs m6175 82.2%   
"Free" reserves Rs m8,3750-   
Net worth Rs m8,43612,599 67.0%   
Long term debt Rs m2024,428 4.6%   
Total assets Rs m12,71223,801 53.4%  
Interest coverage x3.9-7.7 -50.3%   
Debt to equity ratio x00.4 6.8%  
Sales to assets ratio x0.40.7 53.6%   
Return on assets %-2.3-15.2 15.2%  
Return on equity %-4.0-32.1 12.5%  
Return on capital %2.0-19.8 -10.1%  
Exports to sales %43.30-   
Imports to sales %24.40-   
Net fx Rs m8010-   
CASH FLOW
From Operations Rs m-4,2251,370 -308.3%  
From Investments Rs m4,303-421 -1,022.9%  
From Financial Activity Rs m-1844,018 -4.6%  
Net Cashflow Rs m-1054,968 -2.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare PANACEA BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: SANDU PHARMA  NATCO PHARMA  J.B.CHEMICALS  RAJNISH WELLNESS  UNICK FIX-A-FORM AND PRINTERS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.